In 1995 NAMSA became a partial owner of Biomatech, in Lyon, France. For alomst 20 years Biomatech has been a leading contract research organization helping European and worldwide medical device companies bring safe and effective products to market.

By establishing a presence in Europe we expanded our offering to Preclinical and clinical testing. Biomatech and NASMA help medical device manufacturers verify their products are safe and perform according to their intended function. Our unique combination of preclinical and clinical expertise means we deliver the best clinical design and develop cost-effective testing programs that satisfy requirements anywhere you plan to sell your products.

Working with a single source which provides all of these services can benefit manufacturers by:

• Leveraging external expertise to reduce overhead and labor costs
• Establishing a knowledge base that enables the CRO to make recommendations and respond to design changes or modifications in the manufacturing process
• Creating a testing strategy which leverages the results and data obtained early in the process to maximize efficiency of regulatory submissions.